Virus therapy shows promise for deadly brain cancer
Disease control
ENROLLING_BY_INVITATION
This study tests a new oncolytic virus (Ad-TD-nsIL12) for treating high-grade glioma, an aggressive brain cancer. It involves 40 adults aged 18-80 with untreated tumors in specific brain areas. The main goal is to see if the virus improves survival at 12 months.
Phase: PHASE1, PHASE2 • Sponsor: Xiaorong Wu • Aim: Disease control
Last updated May 19, 2026 11:47 UTC